Advertisement

Document › Details
Apitope International N.V.. (10/31/17). "Press Release: Apitope Announces Its Intention to Launch an Initial Public Offering and Listing on Euronext Brussels [Not for release in US, AU, CA, JP or any other jurisdiction where prohibited by applicable law]
![]() |
Region | Brussels |
Country | Belgium | |
![]() |
Organisation | Apitope International N.V. |
Group | Apitope (Group) | |
Organisation 2 | Euronext Brussels | |
Group | Euronext (Group) | |
![]() |
Product | ATX-MS-1467 (Apitope) |
Product 2 | investment banking | |
![]() |
Index term | Apitope–SEVERAL: investment, 201710– IPO at Euronext Brussels incl public offering in BE + private placement to qualified investors outside US |
![]() |
Person | Martin, Keith (Apitope 201810 Non-Executive Director before 2006–201810 CEO RETIRED 10/18) |
Person 2 | Clark, Mary (Optimum Strategic Communications 201710 before Hume Brophy + M:Communications + Capital MSL) | |
Original document
accessed by [iito] on 2017-10-31
Record changed: 2017-11-17 |
Advertisement
![Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px](/banner/iito-20190621-650-089-life-sciences-asia.jpg)
More documents for Apitope (Group)
- [1] Apitope International N.V.. (10/24/18). "Press Release: Apitope Announces Management Changes. Keith Martin to Retire as CEO, Continue as Non-Executive Director – Hayley French Appointed COO and Interim CEO". Hasselt & Chepstow....
- [2] Apitope International N.V.. (9/29/15). "Press Release: Apitope Raises €12 Million in Series B Funding to Progress Treatments for Autoimmune Diseases. Investment led by Wales Life Sciences Fund". Cardiff & Hasselt....
- [3] Apitope International N.V.. (1/8/14). "Press Release: Apitope Led Consortium Receives Up to €6m FP7 Funding to Develop Novel Therapeutic Vaccine for Graves’ Disease". Bristol & Hasselt....
- [4] Apitope International N.V.. (9/3/13). "Press Release: Apitope Announces Positive Results from Clinical Trial of ATX-MS-1467 in Relapsing Multiple Sclerosis". Bristol & Hasselt....
- [5] Apitope International N.V.. (11/26/12). "Press Release: Apitope Completes Recruitment into Its Clinical Trial of ATX-MS-1467 in Multiple Sclerosis". Hamburg & Bonn....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Advertisement

» top